Certified by Founder Lodge
Quell Therapeutics
United Kingdom - London, London
START UP
1 Disclosed Funding Rounds $156,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.
Our company is growing and we are excit
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 29 ,2021 | Series B | $156,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Ernesta Inc. | $20,000,000 | (Mar 12, 2026)
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
Translucent AI | $27,000,000 | (Mar 12, 2026)
zymtrace | $12,200,000 | (Mar 12, 2026)
